Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026

from Medical Digest & Congress Report · host Medical Congress News

Professor Alberico L. Catapano presents findings from the Phase 3 CORALreef AddOn trial, evaluating the oral PCSK9 inhibitor enlicitide decanoate versus bempedoic acid and ezetimibe in statin-treated patients with hypercholesterolemia.Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-enlicitide-decanoate-results-phase-3-coralreef-addon-trial

Episode metadata supplied by the publisher feed · Published Apr 10, 2026

Embed this episode

Attribution link and audio player

Ready to play

Efficacy and Safety of Enlicitide Decanoate: Results from the Phase 3 CORALreef AddOn Trial - report from ACC 2026

0:00 8:10

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

The 2026 NKBA Bath Trends Report

Apr 1, 2026 ·14m

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 8 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 10, 2026.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!